Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Beam Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BEAM
Nasdaq
8731
https://beamtx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Beam Therapeutics Inc
Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
- May 9th, 2024 10:02 am
Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
- May 8th, 2024 2:52 pm
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
- May 8th, 2024 10:30 am
Beam Therapeutics Inc (BEAM) Reports Q1 2024 Earnings: A Detailed Overview
- May 8th, 2024 1:02 am
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
- May 7th, 2024 10:30 am
Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates
- May 2nd, 2024 9:10 pm
Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- May 1st, 2024 2:01 pm
Beam Therapeutics (NASDAQ:BEAM) Is In A Good Position To Deliver On Growth Plans
- Apr 11th, 2024 11:14 am
Why Is Beam Therapeutics (BEAM) Down 22.1% Since Last Earnings Report?
- Mar 28th, 2024 3:30 pm
Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
- Mar 26th, 2024 10:30 am
Beam Therapeutics Inc. (NASDAQ:BEAM) Analysts Are Cutting Their Estimates: Here's What You Need To Know
- Mar 1st, 2024 11:03 am
News Flash: 11 Analysts Think Beam Therapeutics Inc. (NASDAQ:BEAM) Earnings Are Under Threat
- Feb 29th, 2024 10:54 am
Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences
- Feb 28th, 2024 11:30 am
Beam Therapeutics Full Year 2023 Earnings: Beats Expectations
- Feb 28th, 2024 10:38 am
Beam Rockets 26%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
- Feb 27th, 2024 9:01 pm
Beam Therapeutics Stock Jumps To Higher RS Level On Earnings Beat
- Feb 27th, 2024 7:57 pm
Beam Therapeutics Inc (BEAM) Reports Strong Year-End Financials with Key Clinical Milestones on ...
- Feb 27th, 2024 12:11 pm
Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones
- Feb 27th, 2024 11:30 am
Recent uptick might appease Beam Therapeutics Inc. (NASDAQ:BEAM) institutional owners after losing 13% over the past year
- Feb 25th, 2024 1:48 pm
Earnings Preview: Beam Therapeutics Inc. (BEAM) Q4 Earnings Expected to Decline
- Feb 20th, 2024 3:00 pm
Scroll